TCR Vδ4 Antibody, anti-mouse, REAfinity™
Synonyms: TCRD, Tcrdelta, TCRD-V4
RECOMBINANT EXTENDED VALIDATION
Bioz Star90/100 Bioz rating
2 Citations
Clone:
REA372 | GL2
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for TCR Vδ4 Antibody, anti-mouse, REAfinity™

Flow cytometry applications
APC
Biotin
PE
PE-Vio 770
Vio Bright FITC
Recommended dilution:
1:10
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-105-723, 130-105-676
Description:
Splenocytes from C57BL/6 mice were stained with Anti-TCR Vδ4 antibodies or with the corresponding REA Control antibodies (left image) as well as with CD3ε antibodies. Flow cytometry was performed using the MACSQuant® Analyzer. CD19+ B cells were excluded from the analysis. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence or 4',6-diamidino-2-phenylindole (DAPI) fluorescence, as in the case of tandem conjugates.

Application imageView details view details

Application imageView details view details
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
frozen – Acetone
Species tested:
mouse
Recommended dilution:
1:10
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-105-676, 130-105-723
Testing grade:
Extended validation for TCR Vδ4 Antibody, anti-mouse, REAfinity™
Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for TCR Vδ4. Lymphnode cells from C57BL/6 mice were stained with TCR Vδ4 antibodies followed by a suitable counterstain. As a control, TCR Vδ4 antibody staining was omitted and cells were measured in the same channel. Flow cytometry analysis was performed with the MACSQuant Analyzer. Cell debris, dead cells, and doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used

Fixation data

To provide an indication on how an antibody performs after fixation of cells, in-house data on staining results before and after fixation with 3.7% formaldehyde using Miltenyi Biotec antibodies are provided. Different experimental settings may lead to different results.

No fixation
Extended-Validation detailed information image
Post fixation
Extended-Validation detailed information image

Comparison of staining pattern on non-fixed and fixed cells using TCR Vδ4 (REA372). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.

Specifications for TCR Vδ4 Antibody, anti-mouse, REAfinity™
Overview

Clone REA372 recognizes the mouse V delta 4 T cell receptor (TCR Vδ4) antigen, which is the predominant TCR of γ/δ T cells in the intestinal epithelium. The γ/δ TCR is expressed by a small subset of T cells in the thymus, intestinal epithelium, spleen, lymph node, and epidermis.

Additional information: Clone REA372 displays negligible binding to Fc receptors.

Alternative names

TCRD, Tcrdelta, TCRD-V4

Detailed product information

Technical specifications

Clone
REA372
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
TCR Vδ4
Distribution of antigen
T cells
Entrez Gene ID
RRID
AB_2653990, AB_2653993, AB_2653995, AB_2653991, AB_2653987, AB_2653992, AB_2653994, AB_2653988, AB_2653996, AB_2653989

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for TCR Vδ4 Antibody, anti-mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?